Metabolic Impact of Anticancer Drugs Pd<sub>2</sub>Spermine and Cisplatin on the Brain of Healthy Mice
The new palladium agent Pd<sub>2</sub>Spermine (Spm) has been reported to exhibit promising cytotoxic properties, while potentially circumventing the known disadvantages associated to cisplatin therapeutics, namely acquired resistance and high toxicity. This work presents a nuclear magne...
Gardado en:
Main Authors: | Tatiana J. Carneiro (Author), Martin Vojtek (Author), Salomé Gonçalves-Monteiro (Author), João R. Neves (Author), Ana L. M. Batista de Carvalho (Author), Maria Paula M. Marques (Author), Carmen Diniz (Author), Ana M. Gil (Author) |
---|---|
Formato: | Libro |
Publicado: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Acceso en liña: | Connect to this object online. |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares
-
Preclinical Pharmacokinetics and Biodistribution of Anticancer Dinuclear Palladium(II)-Spermine Complex (Pd<sub>2</sub>Spm) in Mice
por: Martin Vojtek, et al.
Publicado: (2021) -
Pd(II) and Pt(II) Trinuclear Chelates with Spermidine: Selective Anticancer Activity towards TNBC-Sensitive and -Resistant to Cisplatin
por: Martin Vojtek, et al.
Publicado: (2023) -
Intracellular PD Modelling (<i>PD</i><sub>i</sub>) for the Prediction of Clinical Activity of Increased Rifampicin Dosing
por: Ghaith Aljayyoussi, et al.
Publicado: (2019) -
Kinin B<sub>1</sub> and B<sub>2</sub> Receptors Contribute to Cisplatin-Induced Painful Peripheral Neuropathy in Male Mice
por: Gabriela Becker, et al.
Publicado: (2023) -
Engineering the Surface of Ti<sub>3</sub>C<sub>2</sub> MXene Nanosheets for High Stability and Multimodal Anticancer Therapy
por: Chiranjeevi Korupalli, et al.
Publicado: (2022)